Affiliation:
1. Department of Zoology, University of Oxford, Oxford, United Kingdom
2. Department of Microbiology, John Radcliffe Hospital, Oxford University Hospitals NHS Trust, Oxford, United Kingdom
3. Nuffield Department of Clinical Laboratory Sciences, Oxford University, John Radcliffe Hospital, Oxford, United Kingdom
4. National Institute for Health Research, Oxford Biomedical Research Centre, John Radcliffe Hospital, Oxford, United Kingdom
Abstract
ABSTRACT
Temporal and seasonal trends in
Campylobacter
genotypes causing human gastroenteritis were investigated in a 6-year study of 3,300 recent isolates from Oxfordshire, United Kingdom. Genotypes (sequence types [ST]) were defined using multilocus sequence typing and assigned to a clonal complex (a cluster of related strains that share four or more identical alleles with a previously defined central genotype). A previously undescribed clonal complex (ST-464) was identified which, together with ST-42, ST-45, and ST-52 complexes, showed increasing incidence. Concurrently, the incidence of ST-574, ST-607, and ST-658 complexes declined. The relative frequencies of three clonal complexes (ST-45, ST-283, and ST-42) peaked during summer and those of two (ST-353 and ST-403) peaked during winter. Nine clonal complexes (ST-22, ST-45, ST-48, ST-61, ST-257, ST-283, ST-403, ST-658, and ST-677) were significantly associated with ciprofloxacin sensitivity (
P
< 0.05). Seven clonal complexes (ST-49, ST-206, ST-354, ST-446, ST-460, ST-464, and ST-607) were associated with ciprofloxacin resistance (
P
< 0.05). Clonal complexes exhibited changing incidence and differences in seasonality and antibiotic resistance phenotype. These data also demonstrated that detailed surveillance at a single site captures information which reflects that observed nationally.
Publisher
American Society for Microbiology
Reference53 articles.
1. British National Formulary. March 2012. British National Formulary online edition. http://www.medicinescomplete.com/mc/bnf/current/102035.htm.
2. Antimicrobial-susceptibility testing of rapidly growing pathogenic bacteria
3. Development, Stability, and Molecular Mechanisms of Macrolide Resistance in
Campylobacter jejuni
4. CDC. 2010. Campylobacter: general information. http://www.cdc.gov/nczved/divisions/dfbmd/diseases/campylobacter/.
5. Ciprofloxacin-resistant campylobacteriosis in the UK